Phibro Animal Health (NASDAQ:PAHC) Shares Gap Up on Strong Earnings

Key Points

• Phibro Animal Health shares jumped after the company reported quarterly EPS of $0.85, beating estimates by $0.14, while revenue of $396.75 million also exceeded expectations.
• The company declared a quarterly dividend of $0.12 per share, equivalent to $0.48 annually and a 1.3% yield.
• Analyst sentiment remains cautious: the stock has a consensus “Hold” rating and a $42.50 price target, while institutional investors own 99.34% of outstanding shares.

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report)'s share price gapped up prior to trading on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $36.09, but opened at $39.39. Phibro Animal Health shares last traded at $36.3350, with a volume of 35,419 shares changing hands.

The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.71 by $0.14. Phibro Animal Health had a net margin of 6.35% and a return on equity of 37.14%. The business had revenue of $396.75 million during the quarter, compared to analyst estimates of $381.18 million. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Wednesday, September 2nd will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Wednesday, September 2nd. Phibro Animal Health's dividend payout ratio is 20.60%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Citigroup lowered their target price on shares of Phibro Animal Health from $62.00 to $44.00 and set a "neutral" rating for the company in a report on Thursday, May 14th. Zacks Research lowered Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a research report on Thursday, May 21st. Wall Street Zen cut Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 9th. Finally, Weiss Ratings downgraded Phibro Animal Health from a "buy (b-)" rating to a "hold (c+)" rating in a report on Monday, June 15th. One equities research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $42.50.

Institutional Investors Weigh In On Phibro Animal Health

A number of institutional investors have recently made changes to their positions in PAHC. 1620 Investment Advisors Inc. increased its holdings in shares of Phibro Animal Health by 77.4% in the 4th quarter. 1620 Investment Advisors Inc. now owns 676 shares of the company's stock worth $25,000 after purchasing an additional 295 shares in the last quarter. Farther Finance Advisors LLC raised its position in Phibro Animal Health by 113.2% in the 4th quarter. Farther Finance Advisors LLC now owns 727 shares of the company's stock worth $27,000 after buying an additional 386 shares during the last quarter. KBC Group NV purchased a new stake in shares of Phibro Animal Health during the 1st quarter valued at about $29,000. Rothschild Investment LLC grew its stake in shares of Phibro Animal Health by 2,500.0% in the fourth quarter. Rothschild Investment LLC now owns 1,040 shares of the company's stock worth $39,000 after acquiring an additional 1,000 shares during the period. Finally, iSAM Funds UK Ltd bought a new stake in shares of Phibro Animal Health in the third quarter worth approximately $61,000. Hedge funds and other institutional investors own 99.34% of the company's stock.

Phibro Animal Health Price Performance

The company has a quick ratio of 1.26, a current ratio of 3.17 and a debt-to-equity ratio of 1.97. The firm's fifty day moving average price is $33.95 and its two-hundred day moving average price is $42.44. The stock has a market capitalization of $1.45 billion, a PE ratio of 15.19, a PEG ratio of 0.51 and a beta of 0.46.

About Phibro Animal Health

Phibro Animal Health Corporation NASDAQ: PAHC is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro's portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source